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vascula
Institut
cent, EAbstract—Nine ultrasound transducers from six ultrasound scanners were assessed for their utility for preclinical
ultrasound imaging. The transducers were: L8-16, L10-22 (Diasus; Dynamic ImagingLtd., Livingston,UK); L17-5,
L15-7io (iU22; Philips, Seattle,WA,USA),HFL38/13-6 (MicroMaxx; Sonosite Inc., Bothell,WA,USA); il3Lv (Vivid
5; GE, Fairfield, CT, USA), RMV 704 (Vevo 770; Visualsonics Inc., Toronto, Canada) andMS550S, MS550D (Vevo
2100; Visualsonics Inc.). A quantitative analysis of the ultrasound images from all nine transducers employed
measurements of the resolution integral as an indication of the versatility and technologyof the ultrasound scanners.
Two other parameters derived from the resolution integral, the characteristic resolution and depth of field, were used
to characterise imaging performance. Six of these transducers were also assessed qualitatively by ultrasonically
scanning 59 female commonmarmosets (Callithrix jacchus) yielding a total of 215 scans. The quantitativemeasure-
ments for each of the transducers were consistent with the results obtained in the qualitative in vivo assessment.
Over a 0–10 mm imaging depth, the values of the resolution integral, characteristic resolution and depth of
field, measured using the Edinburgh Pipe Phantom, ranged in magnitude from 7–72, 93–930 mm and 3.3–9.2
mm respectively. The largest resolution integrals were obtained using the Vevo 770 and Vevo 2100 scanners. The
Edinburgh Pipe Phantom provides a quantitative method of characterising the imaging performance of preclinical
imaging scanners. (E-mail: Carmel.Moran@ed.ac.uk)  2011 World Federation for Ultrasound in Medicine &
Biology.
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Research using small animals has played and continues to
play a key role in the advancement of biological, biomed-
ical and veterinary science. In particular, the mouse
model has become increasingly popular as a research
model due to the fact that the human and mouse genomes
are remarkably similar with over 85% of the genomic
sequences in mice identical to those found in humans
(National Human Genome Research Institute, http://
www.genome.gov). This knowledge of the genomic
sequence enables researchers to knock-out specific genes
enabling the creation of many genetically engineeredddress correspondence to: CarmelM.Moran, Centre for Cardio-
r Sciences, Medical Physics, The Queens Medical Research
e, University of Edinburgh, Edinburgh, 47 Little France Cres-
dinburgh, EH16 4TJ, UK. E-mail: Carmel.Moran@ed.ac.uk
493mouse models of human diseases and, consequently,
helping to decipher disease mechanisms. An additional
advantage of using rat and mouse models is their rela-
tively low maintenance costs and large litter-sizes. The
requirement to monitor disease progression or to deter-
mine which mice are exhibiting a specific genotype
may require the sacrifice ofmany animals. A non-invasive
imaging technique that is capable of high throughput,
relatively inexpensive and with sufficient resolution to
quantify the parameters of interest with high accuracy
may reduce the number of animals that are sacrificed.
A range of imaging techniques are available using knowl-
edge and technology gained from their clinical counter-
parts. These include computed tomography (CT),
magnetic resonance imaging (MRI), positron emission
tomography (PET), optical coherence tomography
(OCT) and high frequency ultrasound imaging. In the
clinical setting, it has been shown that cardiac imaging
Fig. 1. Plot of L against a for a weakly focused ultrasound beam
with low contrast penetration L0 and aminimum beamwidth D0.
a is the reciprocal of beam width, and L(a0) corresponds to the
depth range over which the beam width is less than 1/a0. The
resolution integral R is equal to the area under the curve.
Fig. 2. Image of 330 micron pipe using the RMV 704 probe
illustrating the measurement of L, the depth range over which
the pipe could be imaged. The image of the pipe disappears
(i.e., the pipe is not visible) when the beam width exceeds the
effective diameter of the pipe (shown as D on the image, and
defined in the text).
494 Ultrasound in Medicine and Biology Volume 37, Number 3, 2011with ultrasound provides the most cost-effective imaging
modality (Picano 2005) whilst Olive and Tuveson
(2006) have demonstrated, with respect to preclinical
tumour imaging, that ultrasound demonstrates high
resolution with a low capital cost. Moreover, the advent
of a commercial ultrasound scanner designed specifically
for in vivo microimaging of mice (Foster et al. 2002) has
demonstrated the versatility of the technique including
the use of ultrasound to assess both embryonic develop-
ment (Mu et al. 2006; Phoon et al. 2006, Floch’h et al.
2004), reproductive system (Akirav et al. 2005), eye
development (Cheung et al. 2007), cardiovascular
(Springer et al. 2005, Kaufmann et al. 2007;
Zimmerman et al. 2006, Williams et al. 2007), prostate
imaging (Wirtzfeld et al. 2005) and cancer therapeutics
(Olive and Tuveson 2006; Cheung et al. 2007).
We have previously developed a test object, the
Edinburgh Pipe Phantom, to quantitatively characterise
ultrasound scanners for clinical applications (MacGillivray
et al. 2010). The aim of this article is to describe the devel-
opment of the Edinburgh Pipe Phantom as a means to
assess a range of both clinical and preclinical scanners
for preclinical imaging. These results are then discussed
in the context of images acquired from a preclinical
imaging model (common marmoset [Callithrix jacchus])
using six of the transducers previously assessed with the
Edinburgh Pipe Phantom.
Resolution integral
The quantitative analysis of the ultrasound trans-
ducers used in this study employed measurements of
the resolution integral made using two Edinburgh Pipe
Phantoms. These were composed of tissue-mimicking
material (TMM) (Ramnarine et al. 2001) in which were
embedded a series of anechoic wall-less pipes of varying
diameters (Pye and Ellis 2004). The resolution integral R
is essentially the ratio of the penetration of an ultrasound
beam to the ultrasound beam width. Highly sensitive
transducers combine deep penetration with high resolu-
tion, and so the ratio penetration/beam-width is large.
Figure 1 illustrates this concept for a weakly focused
imaging beam. The abscissa, a, is the inverse of the effec-
tive pipe diameter, calculated as the geometric mean
diameter of the pipe imaged in the lateral and elevation
planes. The ordinate, L, indicates the depth range over
which each pipe can be imaged and is the difference
between the maximum and minimum depths over which
each pipe could be imaged (Fig. 2). Larger pipes are
imaged over greater depths than smaller ones, with the
low contrast penetration defining the limit of detection
for large pipes as a tends to zero. Two other parameters
are defined in Figure 3: depth of field LR and character-
istic resolution DR, and these are related by R 5 LR/DR.
The depth of field defines a region of optimum resolution,and the characteristic resolution is representative of the
lateral and azimuthal resolution within the depth of field.
A transducer suited to a particular imaging application
will have a small characteristic resolution together with
a sufficiently large depth of field for the specific applica-
tion. These concepts have been described with reference
to clinical scanners (Pye et al. 2004, 2010; MacGillivray
et al. 2010).
Fig. 3. Plot of L against a for the same ultrasound beam illus-
trated in Figure 1, illustrating depth of field LR and character-
istic resolution DR. The area under the dashed curve 0-L0-1/
D0 is equal to the resolution integral R. The rectangle 0-LR-
0’-1/DR also has an area equal to R, and line 00’ bisects
both the rectangle and the area under the dashed curve giving
R 5 LR/ DR.
Fig. 4. Plot of L (depth over which pipe can be visualized)
against a (1/effective pipe diameter) for each of the transducers
assessed using the initial pipe phantom.
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Phantom studies
The details of construction of the two Edinburgh
Pipe Phantoms can be found elsewhere (Pye et al. 2004;
Moran et al. 2008; Moran et al. 2010) and will only be
described briefly here. The initial pipe phantom was
constructed from a 250 3 250 3 100 mm block of
TMM. The TMM had attenuation coefficient of 0.5 dB
cm21 MHz21 and speed of sound of 1540 ms21. Eleven
wall-less pipes ranging in diameter from 0.35 mm to
7.9 mm were moulded into the TMM at an angle of 40
to the vertical. A second pipe phantom was constructed
with a range of pipe diameters from 0.045 mm to 1.47
mm embedded in a series of cylinders of TMM of diam-
eter 60 mm and height of 40 mm. The wall-less pipes
were made by inserting stainless steel tube, rod, wire
and surgical suture of appropriate diameter into the
TMM, at an angle of 40 to the vertical, whilst in its liquid
phase. Once the TMM had set, the rods were withdrawn
under submersion in a water and glycerol mixture with
a speed of sound of 1540 ms21.
Each ultrasound transducer that was assessed was
placed on the surface of the TMM and coupled to it
with water/glycerol mixture. An image of the largest
diameter pipe was obtained and the upper portion of the
pipe was imaged with the pipe axis positioned in the
scan plane of the transducer. The image was optimized
(including adjustment of focal position for array trans-
ducers) to visualise the pipe as superficially as possible,
with the transducer held vertically, and the most superfi-
cial region of the pipe that could be detected positioned
directly below the transducer (within 610 of the
vertical). The image was then frozen and a visual assess-
ment was made of the minimum depth at which the pipecould be visualised. To aid in this assessment, a mask of
buff-coloured paper with a slot of width approximately 15
times the wavelength of the centre frequency of the trans-
ducer was used to mask out echoes from neighbouring
regions of the pipe and TMM. The mask was placed
onto the frozen ultrasound image and the slot was moved
up and down along the length of the pipe image to allow
the observer to visualise each short section of the pipe in
turn, compare it with adjacent speckle and identify and
measure the minimum depth below the scanning surface
at which the pipe could be confidently detected. The
transducer was then repositioned and the same procedure
was carried out to identify the maximum depth below
the scanning surface at which the pipe could confidently
be detected. The difference between the maximum and
minimum depths at which the pipe could be detected is
equal to L, the ordinate of the data points in Figures 1,
3, 4, 5 and 6. This procedure was repeated for each pipe
and, as previously described, each value of L was
plotted against a, the reciprocal of the effective pipe
diameter. The effective pipe diameter D shown in
Figure 2 is calculated as the geometric mean of the pipe
diameter in the image and elevation planes and is equal
to d/O(cos 40) for a pipe of diameter d. Using the initial
pipe phantom, up to 11 pipes were scanned. Each pipe
measurement corresponds to one data-point on the curves
in Figure 4. The low contrast penetration depth of the
transducer was determined by measuring the maximum
depth at which speckle could be identified distinctly
from system noise while imaging in real time. This is
shown in Figures 4, 5 and 6 as the intersection of each
data-curve with the ordinate.
Fig. 5. Plot of L against a for the RMV 704 transducer using the
second pipe phantom. The measurements were taken on three
separate occasions over a 15-month period.
496 Ultrasound in Medicine and Biology Volume 37, Number 3, 2011The authors obtained access to a Vevo 2100 scanner
at a later stage, after the in vivo study had been completed.
This scanner is based on solid-state array technology and
two linear array transducers, the MS550S and MS550D,
were assessed using the pipe phantoms. These results
are included for comparison.
The nine ultrasound transducers tested are listed in
Table 1. Only the Vevo 770 RMV 704 (Visualsonics
Inc., Toronto, Canada) transducer and the Vevo 2100
MS550S and MS550D were tested using the second
pipe phantom. The measurements taken using the RMV
704 transducer were on a different Vevo 770 scanner to
that used for the preclinical imaging and were carried
out in the Biological Research Facility of the University
of Edinburgh, UK.Fig. 6. Plot of L against a for Vevo 770 RMV 704 transducer
and Vevo 2100 MS550S and MS550D transducers. For the
RMV 704 transducer, the curves represent the results from the
two methods of measuring the resolution integral (tracking
and non-tracking). The values are the mean and standard devia-
tion of three sets of measurements.In vivo studies
The study described in this articlewas carried out for
the MRC Human Reproductive Sciences Unit, which has
a programme of research on themanipulation of pituitary-
ovarian-uterine function during the normal ovarian cycle
and in early pregnancy (Fraser and Duncan 2009; Wulff
et al. 2002). All ultrasound examinations were
performed in accordance with home office regulations
and approved by the local ethics committee in a manner
similar to that described by Oerke et al. (1996). A total
of 59 adult female marmosets being studied for changes
in ovarian follicular development throughout the ovarian
cycle were ultrasonically scanned over a 6-month period,
yielding a total of 215 scans. The number of scans ob-
tained for each marmoset varied dependent upon the pro-
gramme of research in which the animals were enrolled
(17 marmosets receiving only 1 scan, 39 marmosets
receiving between 2 and 10 scans and 2 marmosets
receiving 12 and 16 scans, respectively).
All marmosets were imaged using a Diasus
(Dynamic Imaging Ltd., Livingston, UK) ultrasound
scanner using either an L8-16 transducer or L10-22 trans-
ducer. On four separate occasions, marmosets were addi-
tionally imaged using one of the transducer/scanner
combinations under evaluation. These marmosets were
initially scanned using the Diasus and then immediately
scanned using the transducer/scanner combination under
evaluation. Except for the Vevo 770 scans, all imaging
was undertaken by the same sonographer who had consid-
erable experience in ultrasonically scanning marmoset
ovaries. For the Vevo 770 scanning session, an experi-
enced Visualsonics demonstrator scanned the animals.
Nine marmosets were scanned with the Sonosite Micro-
Maxx (Sonosite Inc., Bothell, WA, USA) ultrasound
scanner, 14 marmosets with the Visualsonics Vevo 770
and 11 marmosets with the Philips (Seattle, WA, USA)
iU22 and HD11 scanners. Based on the initial results
from our phantom studies, described above, no animals
were scanned with the Vivid 5 scanner (GE, Fairfield,
CT, USA).
The marmosets were hand-held by trained animal
technicians andwere fully conscious throughout the scan-
ning examination. Scans lasted no longer than 3 min. The
abdomen of the marmoset was shaved, warmed gel was
layered onto the skin and the transducer was placed gently
onto the surface of the abdomen. The location of the uterus
was identified on the ultrasound scan (Fig. 7). As a general
rule, at least one of the ovaries proved to be located in the
same field of view as the uterus and was easily located
(Fig. 8). The second ovary was often located more cranial
to the uterus and on the opposite side. Follicles were iden-
tified as circular anechoic structures with distinct bound-
aries. The marmoset commonly ovulates two or three
follicles per cycle and resulting corpora lutea were





Dynamic Imaging Diasus L8-16 8–16
Dynamic Imaging Diasus L10-22 10–22
Philips iU22 L17-5 5–17
Philips iU22 L15-7io 7–15
Sonosite MicroMaxx HFL38/13-6 6–13
GE Vivid 5 i13Lv 10
Visualsonics Vevo 770 RMV 704 20–60
Visualsonics Vevo 2100 MS550D 22–55
Visualsonics Vevo 2100 MS550S 32–56
Imaging performance of high resolution ultrasound scanners d C. M. MORAN et al. 497identified by less distinct boundaries and increased
internal echogenicity within a circular structure. Once
an ovary was located, the transducer was moved cranially
until the top of the ovary was located and then subse-
quently moved toward the lower abdomen to scan through
the whole ovary. The number and size of follicles and
corpora lutea within each ovary was determined.
In addition to the 59 animals scanned, an additional
seven animals from our breeding colony were scanned
during the early stages of pregnancy.RESULTS
Phantom studies
Figures 4, 5 and 6 illustrate the quantitative data
obtained from each of the nine transducers using the
Edinburgh Pipe Phantoms. The curve for each of theFig. 7. Uterus of early pregnancy in the marmtransducers is composed of a minimum of seven data
points, each data point corresponding to a specific pipe.
The resolution integral R, characteristic resolution DR
and depth of field LR were calculated over the full
range of depths imaged (Table 2) and also over a depth
range of 0–10mm appropriate for preclinical imaging
(Table 3).
The resolution integral is equal to the area under
each of the curves in Figures 4, 5 and 6. In Figure 4, it
is evident that the curve for the Vevo 770 RMV 704
transducer does not form a closed curve bounded by
the abscissa, indicating that the smallest wall-less pipe
in the initial phantom (diameter 0.35 mm, a 5 2.5
mm21) could be resolved over a range of depths. The
results of the other transducers tested all formed closed
curves. The iU22 transducers and Diasus transducers
were able to resolve pipe sizes of diameter 0.42 mm
(a5 2.08 mm21) but unable to resolve pipes of diameter
0.35 mm (a 5 2.5 mm21) whilst the Vivid 5 and Micro-
Maxx transducers were unable to resolve the 0.42 mm
diameter pipe size.
Tomake ameasurement of resolution integral for the
Vevo 770RMV704 transducer, it was necessary to use the
second pipe phantom containing smaller diameter pipes.
The results are shown in Figure 5, where each data point
is the mean of three separate measurements on the same
phantom, using the same transducer over a period of 15
months. TheVevo770RMV704 probewas able to resolve
pipe sizes of diameter 0.092 mm (a 5 9.5 mm21)
but unable to resolve pipes of diameter 0.068 mm. Anoset, using a Diasus L10-22 transducer.
Fig. 8. Marmoset uterus and left ovary with dimensions of ovary (7.1 mm) and two follicles (1.7 mm and 0.9 mm) imaged
using a Diasus scanner L8-16 transducer.
498 Ultrasound in Medicine and Biology Volume 37, Number 3, 2011alternative approach to measuring the resolution integral
for the Vevo 770 scanner was also employed by adjusting
the position of the transducer so that the focal region lay
at the specific depth of interest. This was achieved by
varying the distance of the transducer from the phantom,
so that initially the top of each pipe was visualized in
the focal region and then the transducer was moved closer
to the TMM so that the pipe could be imaged as deep into
the TMM as possible. By using this method of ‘‘tracking’’
the visualization of the pipes through the phantom, all
pipes resolved by the RMV 704 could be visualized at
the surface of the TMM. Distance L was then measured
as the vertical distance between the surface of the TMM
and the maximum depth at which the pipe could be visu-
alized. This was repeated for each pipe in turn and the
mean of three measurements was plotted (Fig. 6). ThisTable 2. Resolution integral, characteristic resolution and d
Scanner Transducers Resolution integral, R
Vevo 770 (tracking) RMV 704 72
Vevo 770 (mean, non-tracking) RMV 704 25
Vevo 2100 MS550S 56





Vivid 5 i13Lv 35
MicroMaxx HFL38/13-6 57
Vevo 770 (mean, non-tracking) was the mean of three sets of measurements ta
Vevo 770 (tracking) was calculated by tracking the vertical extent of each pipe
with respect to characteristic resolution such that those transducers with smaltracking technique is consistent with the standard opera-
tion of the Vevo 770 for preclinical imaging, where
coupling gel is often used as a stand-off to ensure that
anatomical structures of interest can be positioned in the
focal region. The results obtained from the Vevo 2100
MS550D and MS550S are also shown on Figure 6. Both
transducers were able to resolve pipe sizes of diameter
0.139 mm (a 5 6.3 mm21) but unable to resolve pipes
of diameter 0.092 mm.
In vivo studies
Due to the nature of the in vivo study, the results pre-
sented below are predominantly qualitative in nature.
Ultrasound images acquired using the Visualsonics
RMV 704 transducer showed greater detail within the
ovarian structures than those obtained using either ofepth of field measurements for each of the transducers











ken using the same Edinburgh Pipe Phantom over a period of 15months.
through the phantom to simulate preclinical use. The results are ranked
lest characteristic resolution are at the top of the table.
Table 3. Resolution integral, characteristic resolution and depth of field for each of the transducers measured over a 0–10 mm
depth range
Scanner Transducers Resolution integral, R Characteristic resolution, DR (mm) Depth of field, LR (mm)
Vevo 770 (tracking) RMV 704 72 93 6.7
Vevo 770 (mean, non-tracking) RMV 704 25 132 3.3
Vevo 2100 MS550S 51 181 9.2
Vevo 2100 MS550D 47 181 8.5
Diasus L8-16 17 480 8.2
Diasus L10-22 15 490 7.5
iU22 L15-7io 16 530 8.5
Vivid 5 i13Lv 15 560 8.3
iU22 L17-5 12 600 7.1
MicroMaxx HFL38/13-6 7 930 6.8
The results are ranked with respect to characteristic resolution such that those transducers with smallest characteristic resolution are at the top of the
table.
Imaging performance of high resolution ultrasound scanners d C. M. MORAN et al. 499the Diasus transducers and, in three ovaries, the Vevo 770
RMV 704 showed a larger number of follicles than were
detected with the Diasus L8-16. This finding was later
confirmed by histologic analysis.
The scans obtained using the MicroMaxx did not
provide any additional qualitative information on the
number and location of follicles in comparison to the
scans obtained using the Diasus and the imaging was
disappointing in the lack of detail that was visualized
in vivo compared with both the Diasus transducers. Both
Philips transducers (L15-7io on the HD11, L17-5 on
the iU22) demonstrated as good a differentiation of the
number and size of follicles within the ovaries as the
Diasus scanner.Based on these invivo results, a qualitative
ranking of the transducers most suitable for preclinical
scanning applications was established (Table 4).
Pregnancy was established by the ultrasonic appear-
ance of an anechoic space in the centre of the uterus
(Fig. 7). Specifically in two instances where the ultra-
sonic image did not identify pregnancy, but palpation
confirmed pregnancy, the animals miscarried at a later
stage. The Diasus scanner had 100% effective determina-
tion of pregnancy and could detect pregnancy between 2
and 3 weeks post ovulation, which was subsequently
confirmed by manual palpation of the uterus at 6 weeks.
In addition, in one early pregnancy imaging session,Table 4. Qualitative in vivo assessment of six
transducers, ranked according to their ability to detect
follicles within marmoset ovaries
Rank Scanner/transducer combinations
1 Vevo 770 RMV 704
2 Diasus L8-16, Diasus L10-22, Philips iU22 L17-5,
Philips iU22 L15-7io
3 MicroMaxx HFL38/13-6
Detection rates were highest with the Vevo 770 RMV 704 probe and
lowest with the MicroMaxx probe, compared with the Diasus L8-16,
Diasus L10-22, Philips iU22 L17-5 and iU22 L15-7io, the latter four
probes giving similar detection rates.the Vevo 770 scanner demonstrated the conceptus and
endometrium in an early pregnancy, which was not
visible in any images acquired with the Diasus L8-16
transducer (Fig. 9).Fig. 9. Top: Visualsonics Vevo 770 RMV 704 image of early
pregnant uterus in a marmoset showing conceptus and endome-
trium. Bottom: Image acquired using a Diasus L8-16 probe on
the same marmoset. No conceptus or endometrium visible.
500 Ultrasound in Medicine and Biology Volume 37, Number 3, 2011DISCUSSION
A transducer that is to be used for preclinical appli-
cations requires high resolution combined with sufficient
depth of field for the specific application. In preclinical
applications, this depth of field is usually, but not always
limited, to approximately 10 mm. In Table 2, the trans-
ducers are ranked with respect to characteristic resolution
such that those with optimal characteristic resolution are
placed toward the top of the table. Although both the
Vevo 770 RMV 704 (untracked) and the Vevo 2100
preclinical probes are ranked toward the top of Table 2,
the corresponding depth of field of these transducers is
limited. In comparison, the two iU22 transducers and
the MicroMaxx transducer demonstrated the greatest
depths of field indicating the versatility of these trans-
ducers over a range of depths. The characteristic resolu-
tion of the clinical scanners varied significantly from
840 mm for the MicroMaxx to 520 mm for the Diasus
L10-22 transducer. These results were consistent with
the observations of the in vivo studies (Table 4) using
the clinical transducers. The iU22 transducers needed
little optimization to obtain good quality images from
the ovaries but in general showed no more detail than
optimized images from the Diasus scanner. (Note,
however, that the L15-7io transducer on the Philips
scanner was tested on the iU22 scanner for the quantita-
tive study but used to image the marmosets on the
HD11). The lack of detail obtained in vivo using the Mi-
croMaxx transducer compared with both the Diasus
transducers is consistent with its larger characteristic
resolution (840 mm vs. 600 and 520 mm).
The Vevo 770 RMV 704 data are of interest. Using
the tracking technique, it demonstrates a large resolution
integral (R 5 72), the smallest characteristic resolution
(93 mm) and a depth of field of 6.7 mm. Using the non-
tracking technique, the resolution integral and depth of
field are substantially smaller (R 5 25, LR 5 3.3 mm)
and the characteristic resolution is larger (132 mm).
Unlike the other transducers used in this study, the
RMV 704 is based on single element technology with
a greater degree of focussing. Consequently, over the
limited depth range of the focal region, the transducer
performs well giving a small characteristic resolution.
When used outside that range, the ability of the trans-
ducer to resolve small objects reduces at a much faster
rate than the array transducers routinely used in clinical
imaging. This was evident from the in vivo studies where,
dependent on the size of the animal to be scanned, Vevo
770 transducers with differing focal positions were used
to obtain optimal images. Indeed, in the Vevo 770 image
in Figure 9 of the pregnant uterus, it is evident that the
posterior edge of the uterus is not visible due to its
distance from the focal region of the transducer.For preclinical imaging, structures of interest are
generally located at less than 10 mm depth and the data
presented in Table 3 are particularly relevant. The resolu-
tion integral, characteristic resolution and depth of field
are calculated over a depth of 1–10 mm and ranked with
respect to characteristic resolution (as in Table 2). Over
this limited imaging depth, the resolution integrals calcu-
lated from 0–10 mm depth for the Vevo 770 RMV 704
(tracking) and the Vevo 2100 transducers are more than
three times greater than those obtained from the clinical
scanners and they have the smallest characteristic resolu-
tions. The resolution integral values presented in Table 3
effectively form an order of merit for preclinical imaging,
with the Vevo 770 (particularly when used in tracking
mode) and Vevo 2100 being the scanners of choice.
CONCLUSION
In this study, a quantitative assessment of the abilities
of a series of nine ultrasound transducers to image at
depths associatedwith preclinical applicationswas under-
taken. The resolution integral measurements obtained
over a 0–10 mm depth range enabled the transducers to
be ranked in order of merit for preclinical imaging. These
results were consistent with the data acquired during
a qualitative in vivo assessment to determine the ability
of six of the transducers to image follicles within the
ovaries of small animals.
This study demonstrates the ability of the resolu-
tion integral, implemented using two Edinburgh Pipe
Phantoms, to quantify the acoustic characteristics of
transducer/scanner combinations for specific imaging
applications, in this instance over a 10 mm depth for
preclinical applications. Our long-term objective is to
use this phantom to routinely assess the imaging perfor-
mance of preclinical scanners.
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